Reuters logo
3 years ago
BRIEF-Sangui Biotech International H1 revenues of $104,906, up 74.0 pct
February 12, 2015 / 11:12 AM / 3 years ago

BRIEF-Sangui Biotech International H1 revenues of $104,906, up 74.0 pct

Feb 12 (Reuters) - Sangui Biotech International Inc :

* Revenues slightly improved in the first half of the 2015 financial year

* H1 revenues from product sales and royalties in amount of $104,906, an increase of 74.0 pct over revenues

* H1 research and development expenses amounted to $134,977 (H1/2014: $107,234)

* Says H1 net loss attributable to shareholders of parent company came to $355,928 (H1/2014: $570,032) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below